The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis
Abstract
BACKGROUND Previous studies found conflicting results about whether atopic dermatitis (AD) begins in adulthood. OBJECTIVE To determine rates, predictors, and phenotypic differences of adult-onset AD. METHODS A systematic review was performed with all published observational studies in Medline, Embase, GREAT (Global Resource of EczemA Trials), LILACS (Latin American and Caribbean Health Sciences Literature), Cochrane Library, and Scopus that analyzed the age of AD onset beyond 10 years of age. At least two reviewers performed study title, abstract review, and data extraction. Pooled meta-analysis of the proportion of adult-onset AD was performed by using random-effects weighting (I2 = 99.3%). RESULTS Overall, 25 studies met inclusion criteria. Seventeen studies reported age of AD onset as after 16 years of age and had sufficient data for meta-analysis. The pooled proportion (95% confidence interval) of adult-onset AD was 26.1% (16.5%-37.2%). Similar results were found in sensitivity analyses by AD diagnostic method, study region, and sex. Phenotypic differences were observed across studies for adult-onset and child-onset AD, including higher rates of foot dermatitis and personal history of atopy but lower rates of flexural lesions and other signs and symptoms. LIMITATIONS Characteristics of adult-onset versus child-onset AD were not commonly reported. CONCLUSION AD is not only a disease of childhood; 1 in 4 adults with AD report adult-onset disease, which has distinct clinical characteristics as compared to child-onset AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atopic dermatitis and the atopic march
Spergel, J. M., & Paller, A. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.033 · Cited by 1,229
Public Health Burden and Epidemiology of Atopic Dermatitis
Silverberg, J. I. (2017) · Dermatologic Clinics · doi:10.1016/j.det.2017.02.002 · Cited by 400
Self-citationMortz, C. G., Andersen, K. E., Dellgren, C., Barington, T., & Bindslev‐Jensen, C. (2015) · Allergy · doi:10.1111/all.12619 · Cited by 267
Cited by
The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017*
Laughter, M. R., Maymone, M. B. C., Mashayekhi, S., Arents, B. W. M., Karimkhani, C., Langan, S. M., Dellavalle, R. P., & Flohr, C. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19580 · Cited by 621
Comorbidities and the impact of atopic dermatitis
Silverberg, J. I. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.04.020 · Cited by 431
Self-citationShin, Y. H., Hwang, J., Kwon, R., Lee, S. W., Kim, M. S., Collaborators, G. 2. A. D., Shin, J. I., & Yon, D. K. (2023) · Allergy · doi:10.1111/all.15807 · Cited by 431
Chiesa Fuxench, Z. C., Block, J. K., Boguniewicz, M., Boyle, J., Fonacier, L., Gelfand, J. M., Grayson, M. H., Margolis, D. J., Mitchell, L., Silverberg, J. I., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.08.028 · Cited by 419
Self-citationChu, D. K., Schneider, L., Asiniwasis, R. N., Boguniewicz, M., De Benedetto, A., Ellison, K., Frazier, W. T., Greenhawt, M., Huynh, J., Kim, E., et al. (2024) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2023.11.009 · Cited by 380
Self-citationGuttman-Yassky, E., Thaçi, D., Pangan, A. L., Hong, H. C.-H., Papp, K. A., Reich, K., Beck, L. A., Mohamed, M.-E. F., Othman, A. A., Anderson, J. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.025 · Cited by 369
Self-citationTwo Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Guttman-Yassky, E., Thaçi, D., Irvine, A. D., Stein Gold, L., Blauvelt, A., Simpson, E. L., Chu, C.-Y., Liu, Z., Gontijo Lima, R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2206714 · Cited by 345
Self-citationUpdate on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection
Fishbein, A. B., Silverberg, J. I., Wilson, E. J., & Ong, P. Y. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.06.044 · Cited by 321
Self-citationThe prevalence and persistence of atopic dermatitis in urban United States children
McKenzie, C., & Silverberg, J. I. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.05.014 · Cited by 105
Self-citationEfficacy of biologics in atopic dermatitis
Wu, J., & Guttman-Yassky, E. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1722998 · Cited by 46
“In one meta-analysis, important clinical differences emerged between adult-onset versus childonset AD, including a greater frequency of foot dermatitis and a lower proportion of flexural manifestations [4].”
BackgroundMendelian randomization studies in atopic dermatitis: a systematic review
Elhage, K. G., Kranyak, A., Jin, J. Q., Haran, K., Spencer, R. K., Smith, P. L., Davis, M. S., Hakimi, M., Bhutani, T., & Liao, W. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.10.016 · Cited by 31
Gu, X., Jing, D., Xiao, Y., Zhou, G., Yang, S., Liu, H., Chen, X., & Shen, M. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114683 · Cited by 28
Genetic Architectures Underlie Onset Age of Atopic Dermatitis
Hikino, K., Tanaka, N., Koido, M., Tomizuka, K., Koike, Y., Ito, S., Suzuki, A., Momozawa, Y., Kamatani, Y., Mushiroda, T., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.06.010 · Cited by 5
Metadata
- Authors
- Lee, H. H., Patel, K. R., Singam, V., Rastogi, S., & Silverberg, J. I.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 80
- Issue
- 6
- Pages
- 1526-1532.e7
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2807010662
- Cited by
- 208
- References
- 3
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.